Atlas Trials

Study of SGN-40 in Patients With Refractory or Recurrent Multiple Myeloma

Clinical trial NCT00079716 · COMPLETED

Trial details

NCT number
NCT00079716
Sponsor
Seagen Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2004-03-01
Primary completion
2007-08-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.